NEW YORK, NY / ACCESS Newswire / August 16, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Lantheus Holdings, Inc. ("Lantheus Holdings, Inc.") (NASDAQ:LNTH) concerning possible violations of federal securities laws. On August 6, 2025, Lantheus reported its financial results for the second quarter of 2025 which missed analyst […]
NEW YORK, NY / ACCESS Newswire / August 16, 2025 / If you suffered a loss on your Neogen Corporation (NASDAQ:NEOG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/neogen-corporation-lawsuit-submission-form?prid=161818&wire=1&utm_campaign=23 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESS Newswire / August 16, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Anika Therapeutics, Inc. ("Anika Therapeutics, Inc.") (NASDAQ:ANIK) concerning possible violations of federal securities laws. Anika issued a press release on July 30, 2025, "announc[ing] topline results from its U.S. pivotal clinical trial
NEW YORK, NY / ACCESS Newswire / August 16, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Bumble Inc. ("Bumble Inc.") (NASDAQ:BMBL) concerning possible violations of federal securities laws. Bumble released its second quarter 2025 results, after the market closed on August 6, 2025. Among other items, the Company
NEW YORK, NY / ACCESS Newswire / August 16, 2025 / If you suffered a loss on your Lineage, Inc. (NASDAQ:LINE) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/lineage-inc-lawsuit-submission-form?prid=161821&wire=1&utm_campaign=26 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESS Newswire / August 16, 2025 / If you suffered a loss on your Hims & Hers Health, Inc. (NYSE:HIMS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/hims-hers-health-inc-lawsuit-submission-form?prid=161822&wire=1&utm_campaign=28 or contact Joseph E. Levi, Esq. via email at
NEW YORK, NY / ACCESS Newswire / August 16, 2025 / If you suffered a loss on your Altimmune, Inc. (NASDAQ:ALT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/altimmune-inc-lawsuit-submission-form-2?prid=161826&wire=1&utm_campaign=14 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESS Newswire / August 16, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Marex Group plc ("Marex Group plc") (NASDAQ:MRX) concerning possible violations of federal securities laws. NINGI Research released a report alleging that Marex Group has concealed nearly $1 billion in off-balance-sheet derivatives exposure
NEW YORK, NY / ACCESS Newswire / August 16, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Praxis Precision Medicines, Inc. ("Praxis Precision Medicines, Inc.") (NASDAQ:PRAX) concerning possible violations of federal securities laws. Praxis Precision Medicines, Inc. issued a press release on August 4, 2025, announcing its financial results
NEW YORK, NY / ACCESS Newswire / August 16, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of GSK plc ("GSK plc") (NYSE:GSK) concerning possible violations of federal securities laws. GSK issued a press release on July 17, 2025, announcing "that the US Food and Drug Administration (FDA) Oncologic Drugs